6533b7d1fe1ef96bd125c13a
RESEARCH PRODUCT
Genotype-Phenotype Analysis across 130,422 Genetic Variants Identifies Rspo3 as the First Genome-Wide Significant Modifier Gene in Primary Sclerosing Cholangitis
R. AlbertsE.m. De VriesG. AlexanderD. AlvaroA. BergquistU. BeuersE. BjörnssonK.m. BobergC.l. BowlusR.w. ChapmanO. ChazouilléresA. CheungG. DalekosB. EksteenJ.e. EatonD. EllinghausM. FärkkiläE.a. FestenA. FloreaniT. FolseraasE. GoodeD.n. GotthardtG.m. HirschfieldB. Van HoekS. HohenesterK. HolmJ.r. HovF. ImhannP. InvernizziX. JiangB.d. JuranK.n. LazaridisV. LeppaJ.z. LiuJ. LöfbergM.p. MannsH.-u. MarschallM. MarzioniA.l. MasonE. MelumT. MüllerP. MilkiewiczA. ParesV. PelkonenM. PinzaniK. RomboutsC. RuppS.m. RushbrookC. RustF. SampaziotisR.n. SandfordC. SchrammS. SchreiberE. SchrumpfM. SilverbergB. SrivastavaM. SterneckA. TeufelL. TittmannL. VallierA.v. VilaB.a. De VriesT.j. WeismüllerC. WijmengaK. ZachouA. FrankeC.a. AndersonT.h. KarlsenC.y. PonsioenK. Weersmasubject
GeneticsHepatologyIn silicoBiologymedicine.diseaseGenomeInflammatory bowel diseasePrimary sclerosing cholangitis03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisGene duplicationGenotypemedicine030211 gastroenterology & hepatologyCopy-number variationGenedescription
Background Ulcerative colitis (UC), a complex polygenic disorder, is one of the main subphenotypes of inflammatory bowel disease. A comprehensive dissection of the genetic etiology of UC needs to assess the contribution of rare genetic variants including copy number variations (CNVs) to disease risk. In this study, we performed a multi-step genome-wide case-control analysis to interrogate the presence of disease-relevant rare copy number variants. Methods One thousand one hundred twenty-one German UC patients and 1770 healthy controls were initially screened for rare deletions and duplications employing SNP-array data. Quantitative PCR and high density custom array-CGH were used for validation of identified CNVs and fine mapping. Two main follow-up panels consisted of an independent cohort of 451 cases and 1274 controls, in which CNVs were assayed through quantitative PCR, and a British cohort of 2396 cases versus 4886 controls with CNV genotypes based on array data. Additional sample sets were assessed for targeted and in silico replication. Results Twenty-four rare copy number variants (14 deletions and 10 duplications), overrepresented in UC patients were identified in the initial screening panel. Follow-up of these CNV regions in four independent case-control series as well as an additional public in silico control group (totaling 4439 UC patients and 15,961 healthy controls) revealed three copy number variants enriched in UC patients; a 15.8 kb deletion upstream of ABCC4 and CLDN10 at13q32.1 (0.43 % cases, 0.11 % controls), a 119 kb duplication at 7p22.1, overlapping RNF216, ZNF815, OCM and CCZ1 (0.13 % cases, 0.01 % controls) and a 134 kb large duplication upstream of the KCNK9 gene at 8q24.3 (0.22 % carriers among cases, 0.03 % carriers among controls). The trend of association with UC was present after the P-values were corrected for combining data from different subpopulations. Break-point mapping of the deleted region suggested non-allelic homologous recombination as the mechanism underlying its formation. Conclusion Our study presents a pragmatic approach for effective rare CNV screening of SNP-array data sets and implicates the potential contribution of rare structural variants in the pathogenesis of UC.
year | journal | country | edition | language |
---|---|---|---|---|
2016-01-01 | Journal of Hepatology |